Additionally, sialic acid‐modified colchicine derivatives specifically block TAN infiltration into tumours, reducing their suppressive effects on T cells and significantly enhancing the efficacy of PD‐L1 antibodies in advanced tumour models. The gene discussed is CD274; the disease is neoplasm.